Evaluating rates of skin colonisation with MRSA or Group A Streptococci

Grant ID: EMSS-311R26-2016

Project Summary

Group A Streptococcal (GAS) is known to be the cause of Acute Rheumatic Fever (ARF) and Chronic Rheumatic Heart Disease (CRHD).

Worldwide Community acquired (CA) Methicillin Resistant Staphylococcus Aureus (MRSA) is an increasing problem which has also been identified in Australia since the 1990s. At times, the rates in North West HHS have been as high as 30%. This has implications for both the local HHS and the health system more broadly for patients that then require transfer to other facilities.

The purpose of this research is to conduct a snapshot study for the evaluation of rate of skin colonisation or infection with MRSA and/or Group A Streptococci (SCIMAG).

The aim of this study is to establish the percentage of patients with skin colonisation and/or infection with GAS and/or MRSA. It will assess the utility of point of care (non-culture) methods to detect colonisation and/or infection. This is of relevance not only for the Mount Isa Hospital Emergency Department (MIH ED), but both State-wide and nation-wide.

Findings from this research will contribute to the development and implementation of a guideline for diagnosis and antibiotic treatment (antibiotic stewardship) for Mount Isa and the North West. This guideline would be applicable to other States.

Leveraged Funds

- Northern Queensland Primary Health Network: $70,000


Amount Awarded


Grant Scheme


Principal Investigator:
Dr Ulrich Orda

Co Investigators:
Dr Patricia Orda
Dr Duy Le
Dr Maria Obajdin

Associate Investigators:
Dr Geoffrey Rofe
Prof Ronny Gunnarsson
Prof Biswadev Mitra
Prof Mark Fitzgerald
Prof Asha Bowen



  • EMF Case study

  • CONTACT US +61 7 3112 8668 info@emfoundation.org.au Suite 1A 34 Sherwood Road Toowong, Qld 4066